Zobrazeno 1 - 10
of 48
pro vyhledávání: '"Motonori Sato"'
Autor:
Motonori Sato, Yoshifumi Tamura, Hideyoshi Kaga, Nozomu Yamasaki, Satoshi Kadowaki, Daisuke Sugimoto, Takashi Nakagata, Yuki Someya, Yuya Nishida, Ryuzo Kawamori, Hirotaka Watada
Publikováno v:
Frontiers in Endocrinology, Vol 15 (2024)
ObjectiveThe proportion of young Japanese women who are underweight is exceptionally high. We previously showed that the prevalence of impaired glucose tolerance (IGT) was high in underweight young Japanese women, and that IGT was characterized by hi
Externí odkaz:
https://doaj.org/article/b863e3c5a1de42ab8844da0de810d629
The role of DPYD and the effects of DPYD suppressor luteolin combined with 5‐FU in pancreatic cancer
Autor:
Hiroyuki Kato, Motonori Sato, Aya Naiki‐Ito, Shingo Inaguma, Makoto Sano, Masayuki Komura, Yuko Nagayasu, Kuang Xiaochen, Akihisa Kato, Yoichi Matsuo, Hideaki Ijichi, Satoru Takahashi
Publikováno v:
Cancer Medicine, Vol 13, Iss 16, Pp n/a-n/a (2024)
Abstract Background Despite advances in the treatment of cancer, pancreatic ductal adenocarcinoma (PDAC) remains highly lethal due to the lack of effective therapies. Our previous study showed that Luteolin (Lut), a flavonoid, suppressed pancreatocar
Externí odkaz:
https://doaj.org/article/84b4b5aa58d74562a514aeca0702d8b2
Autor:
Hideyoshi Kaga, Yoshifumi Tamura, Yuki Someya, Hitoshi Naito, Hiroki Tabata, Saori Kakehi, Nozomu Yamasaki, Motonori Sato, Satoshi Kadowaki, Ruriko Suzuki, Daisuke Sugimoto, Ryuzo Kawamori, Hirotaka Watada
Publikováno v:
Journal of Cachexia, Sarcopenia and Muscle, Vol 13, Iss 6, Pp 2835-2842 (2022)
Abstract Background Sarcopenia is a major cause of disability in the elderly. Although type 2 diabetes is a risk factor for increased sarcopenia, the relationship between prediabetes and sarcopenia has not been elucidated. We aimed to examine the rel
Externí odkaz:
https://doaj.org/article/c88437440ec94d29a7482c49df611fdd
Autor:
Takashi Nakagata, Yoshifumi Tamura, Hideyoshi Kaga, Motonori Sato, Nozomu Yamasaki, Yuki Someya, Satoshi Kadowaki, Daisuke Sugimoto, Hiroaki Satoh, Ryuzo Kawamori, Hirotaka Watada
Publikováno v:
Journal of Diabetes Investigation, Vol 12, Iss 5, Pp 756-762 (2021)
Abstract Aims/Introduction As a low‐carbohydrate diet and the use of sodium–glucose transporter‐2 inhibitors are both known to increase D‐beta‐hydroxybutyrate levels, the effect of these levels on glucose metabolism has attracted attention.
Externí odkaz:
https://doaj.org/article/ae23be199e4d45878de1a8bc6ae67f7d
Autor:
Motonori Sato, Yoshifumi Tamura, Yuki Someya, Kageumi Takeno, Hideyoshi Kaga, Satoshi Kadowaki, Daisuke Sugimoto, Saori Kakehi, Takashi Funayama, Yasuhiko Furukawa, Ruriko Suzuki, Takashi Nakagata, Miho Nishitani‐Yokoyama, Kazunori Shimada, Hiroyuki Daida, Shigeki Aoki, Hiroaki Sato, Ryuzo Kawamori, Hirotaka Watada
Publikováno v:
Journal of Diabetes Investigation, Vol 11, Iss 6, Pp 1520-1523 (2020)
Abstract Elevated 1‐h plasma glucose (1h‐PG; ≥155 mg/dL) during an oral glucose tolerance test is a risk factor for type 2 diabetes. However, the metabolic characteristics of non‐obese Asians with elevated 1h‐PG are unknown. Thus, we studie
Externí odkaz:
https://doaj.org/article/f39f9fa3791b4723aaa1a73ea1a725a4
Autor:
Motonori Sato, Yoshifumi Tamura, Hideyoshi Kaga, Nozomu Yamasaki, Mai Kiya, Satoshi Kadowaki, Daisuke Sugimoto, Takashi Funayama, Yuki Someya, Saori Kakehi, Shuko Nojiri, Hiroaki Satoh, Ryuzo Kawamori, Hirotaka Watada
Publikováno v:
Biomedicines, Vol 9, Iss 9, p 1154 (2021)
Background: Decreased insulin clearance could be a relatively upstream abnormality in obesity, metabolic syndrome, and nonalcoholic fatty liver disease. Previous studies have shown that sodium-glucose cotransporter 2 inhibitor (SGLT2i) increases insu
Externí odkaz:
https://doaj.org/article/345cd8f6668b42e494610487fec43725
Autor:
Nozomu Yamasaki, Yoshifumi Tamura, Kageumi Takeno, Saori Kakehi, Yuki Someya, Takashi Funayama, Yasuhiko Furukawa, Hideyoshi Kaga, Ruriko Suzuki, Daisuke Sugimoto, Satoshi Kadowaki, Motonori Sato, Takashi Nakagata, Miho Nishitani-Yokoyama, Kazunori Shimada, Hiroyuki Daida, Shigeki Aoki, Hiroaki Satoh, Ryuzo Kawamori, Hirotaka Watada
Publikováno v:
Scientific Reports, Vol 11, Iss 1, Pp 1-1 (2021)
An amendment to this paper has been published and can be accessed via a link at the top of the paper.
Externí odkaz:
https://doaj.org/article/545d4ff045824a3cbcd1e4a3f355a0d7
Autor:
Watada, Satoshi Kadowaki, Yoshifumi Tamura, Daisuke Sugimoto, Hideyoshi Kaga, Ruriko Suzuki, Yuki Someya, Nozomu Yamasaki, Motonori Sato, Saori Kakehi, Akio Kanazawa, Ryuzo Kawamori, Hirotaka
Publikováno v:
Journal of Clinical Medicine; Volume 12; Issue 12; Pages: 4084
A short-term high-calorie high-fat diet (HCHFD) impairs insulin sensitivity in non-obese South Asian but not Caucasian men; however, the effect of short-term HCHFD on insulin sensitivity in East Asians is unknown. We recruited 21 healthy non-obese Ja
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=multidiscipl::31fd18f921975f3b62040ba941eb1c27
Autor:
Kazunori Shimada, Kageumi Takeno, Saori Kakehi, Takashi Funayama, Yoshifumi Tamura, Daisuke Sugimoto, Nozomu Yamasaki, Ruriko Suzuki, Yasuhiko Furukawa, Hiroaki Satoh, Motonori Sato, Shigeki Aoki, Ryuzo Kawamori, Miho Nishitani-Yokoyama, Hiroyuki Daida, Hideyoshi Kaga, Satoshi Kadowaki, Yuki Someya, Hirotaka Watada, Mai Kiya
Publikováno v:
The Journal of Clinical Endocrinology & Metabolism. 106:e2228-e2238
Context Adipose tissue dysfunction is characterized by decreased adiponectin (AN) levels and impaired adipose tissue insulin sensitivity (ATIS) and is associated with metabolic disorders. While Asians readily develop metabolic disease without obesity
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6c083b1b52294b0a615a9b41e00b8a9e
https://doi.org/10.1210/clinem/dgab037
https://doi.org/10.1210/clinem/dgab037
Autor:
Takashi Funayama, Yoshifumi Tamura, Shuko Nojiri, Hiroaki Satoh, Yasuhiko Furukawa, Mai Kiya, Motonori Sato, Satoshi Kadowaki, Yuki Someya, Hirotaka Watada, Nozomu Yamasaki, Hideyoshi Kaga, Ryuzo Kawamori, Ruriko Suzuki, Saori Kakehi, Daisuke Sugimoto
Publikováno v:
Diabetes, Obesity and Metabolism. 23:1092-1100
Aim To investigate whether changes in endogenous glucose production (EGP) and insulin and glucagon levels are elicited by the decrease in plasma glucose (PG) levels induced by the sodium-glucose co-transporter-2 (SGLT2) inhibitor tofogliflozin. Mater
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::12a550b9041a57222874d97c164062cf
https://doi.org/10.1111/dom.14312
https://doi.org/10.1111/dom.14312